Adrenomed
Adrenomed is a sepsis drug.
1
Funding Rounds
$26.3m
Money raised
Funding series
Funding Series Analysis
The company Adrenomed has raised a total of $26.3m in funding over 1 rounds.
Key Insights:
- Adrenomed Series E round, November 2020: $26.3m
Adrenomed Series E round, November 2020
$26.3m
Industries
Adrenomed is active in the following industries: